Log In
BCIQ
Print this Print this
 

IMR-687

  Manage Alerts
Collapse Summary General Information
Company H. Lundbeck A/S
DescriptionPhosphodiesterase-9 (PDE-9) inhibitor
Molecular Target Phosphodiesterase-9 (PDE-9)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSickle cell disease
Indication DetailsTreat sickle cell disease
Regulatory Designation
PartnerImara Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/14/2016

Undisclosed

0

Undisclosed

Get a free BioCentury trial today